Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homeodomain Proteins | 17 | 2022 | 74 | 4.230 |
Why?
|
| DNA-Binding Proteins | 13 | 2021 | 482 | 2.710 |
Why?
|
| Precursor Cells, B-Lymphoid | 3 | 2021 | 12 | 1.860 |
Why?
|
| VDJ Recombinases | 10 | 2016 | 12 | 1.650 |
Why?
|
| DNA | 9 | 2015 | 365 | 1.540 |
Why?
|
| Cell Nucleus | 3 | 2019 | 135 | 1.430 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 245 | 1.370 |
Why?
|
| V(D)J Recombination | 2 | 2022 | 4 | 1.020 |
Why?
|
| Zinc | 6 | 2011 | 53 | 0.910 |
Why?
|
| Protein Sorting Signals | 2 | 2022 | 17 | 0.890 |
Why?
|
| DNA Damage | 1 | 2021 | 147 | 0.670 |
Why?
|
| Gene Expression | 2 | 2021 | 405 | 0.670 |
Why?
|
| Protein Binding | 14 | 2021 | 631 | 0.640 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2016 | 24 | 0.610 |
Why?
|
| Protein Conformation | 11 | 2016 | 250 | 0.590 |
Why?
|
| Protein Structure, Tertiary | 12 | 2015 | 283 | 0.590 |
Why?
|
| Base Sequence | 7 | 2011 | 573 | 0.590 |
Why?
|
| Mutation | 7 | 2021 | 820 | 0.550 |
Why?
|
| Recombination, Genetic | 3 | 2009 | 61 | 0.540 |
Why?
|
| DNA Cleavage | 3 | 2016 | 12 | 0.540 |
Why?
|
| Centrosome | 1 | 2015 | 10 | 0.480 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 50 | 0.460 |
Why?
|
| Binding Sites | 11 | 2015 | 338 | 0.450 |
Why?
|
| Animals | 19 | 2022 | 9954 | 0.440 |
Why?
|
| Mice | 13 | 2022 | 4402 | 0.420 |
Why?
|
| Gene Rearrangement | 3 | 2003 | 13 | 0.410 |
Why?
|
| Nucleic Acids | 1 | 2011 | 10 | 0.380 |
Why?
|
| Temperature | 2 | 2009 | 207 | 0.350 |
Why?
|
| Protein Subunits | 1 | 2009 | 40 | 0.320 |
Why?
|
| Dimerization | 7 | 2009 | 75 | 0.320 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 3 | 2016 | 54 | 0.300 |
Why?
|
| Cell Line | 6 | 2021 | 671 | 0.290 |
Why?
|
| DNA Repair | 2 | 2021 | 82 | 0.290 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2012 | 228 | 0.270 |
Why?
|
| Peptide Fragments | 2 | 2021 | 197 | 0.270 |
Why?
|
| Humans | 16 | 2022 | 26856 | 0.230 |
Why?
|
| Lipopolysaccharides | 2 | 2022 | 151 | 0.230 |
Why?
|
| Substrate Specificity | 3 | 2011 | 149 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 93 | 0.220 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 17 | 0.220 |
Why?
|
| Receptors, Antigen | 1 | 2022 | 4 | 0.210 |
Why?
|
| Purines | 1 | 2022 | 14 | 0.210 |
Why?
|
| HEK293 Cells | 2 | 2021 | 173 | 0.200 |
Why?
|
| Lung Injury | 1 | 2022 | 31 | 0.200 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 1036 | 0.200 |
Why?
|
| Pyrimidines | 1 | 2022 | 121 | 0.190 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2021 | 23 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 69 | 0.180 |
Why?
|
| Catalytic Domain | 2 | 2015 | 77 | 0.180 |
Why?
|
| Cell Cycle | 1 | 2021 | 155 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 109 | 0.180 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 4 | 0.170 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1999 | 26 | 0.170 |
Why?
|
| Oligonucleotides | 3 | 2004 | 27 | 0.160 |
Why?
|
| Histones | 1 | 2019 | 90 | 0.160 |
Why?
|
| DNA Nucleotidyltransferases | 3 | 2003 | 3 | 0.160 |
Why?
|
| Chromatin | 1 | 2019 | 77 | 0.150 |
Why?
|
| Macromolecular Substances | 4 | 2009 | 52 | 0.150 |
Why?
|
| Models, Molecular | 8 | 2012 | 441 | 0.140 |
Why?
|
| Protein Stability | 3 | 2012 | 42 | 0.140 |
Why?
|
| Inflammation | 1 | 2021 | 598 | 0.140 |
Why?
|
| Protein Structure, Secondary | 5 | 2014 | 130 | 0.140 |
Why?
|
| Escherichia coli | 5 | 2012 | 328 | 0.140 |
Why?
|
| Circular Dichroism | 4 | 2012 | 43 | 0.130 |
Why?
|
| Catalysis | 3 | 2008 | 133 | 0.130 |
Why?
|
| Light | 1 | 2016 | 117 | 0.120 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 19 | 0.120 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 15 | 0.120 |
Why?
|
| Radiation, Ionizing | 1 | 2015 | 25 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2015 | 969 | 0.120 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2016 | 115 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 131 | 0.120 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 3 | 0.110 |
Why?
|
| Dictyostelium | 1 | 2014 | 5 | 0.110 |
Why?
|
| F-Box Proteins | 1 | 2014 | 10 | 0.110 |
Why?
|
| Proteins | 1 | 1996 | 244 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 161 | 0.110 |
Why?
|
| Protein Folding | 3 | 2009 | 47 | 0.110 |
Why?
|
| Protozoan Proteins | 1 | 2014 | 47 | 0.110 |
Why?
|
| Fungal Proteins | 1 | 1994 | 72 | 0.110 |
Why?
|
| Eye Proteins | 2 | 2012 | 197 | 0.100 |
Why?
|
| Intermediate Filament Proteins | 1 | 2012 | 21 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 110 | 0.100 |
Why?
|
| Oncostatin M Receptor beta Subunit | 1 | 2012 | 1 | 0.100 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2012 | 3 | 0.100 |
Why?
|
| Oncostatin M | 1 | 2012 | 4 | 0.100 |
Why?
|
| Zinc Fingers | 3 | 2004 | 26 | 0.100 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cytochromes b5 | 1 | 1991 | 1 | 0.100 |
Why?
|
| Static Electricity | 1 | 2011 | 34 | 0.100 |
Why?
|
| Amino Acid Sequence | 4 | 2021 | 674 | 0.100 |
Why?
|
| Cytochrome c Group | 1 | 1991 | 10 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 143 | 0.100 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2011 | 5 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 151 | 0.100 |
Why?
|
| cis-trans-Isomerases | 1 | 2011 | 25 | 0.090 |
Why?
|
| Membrane Lipids | 1 | 2011 | 21 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 95 | 0.090 |
Why?
|
| Peptides | 2 | 2022 | 280 | 0.090 |
Why?
|
| Liposomes | 1 | 2011 | 142 | 0.090 |
Why?
|
| Transcription Factors | 1 | 1994 | 511 | 0.090 |
Why?
|
| Computational Biology | 1 | 2011 | 150 | 0.080 |
Why?
|
| Chromatography, Gel | 1 | 2009 | 36 | 0.080 |
Why?
|
| Mutagenesis | 1 | 2009 | 45 | 0.080 |
Why?
|
| Ions | 1 | 2009 | 18 | 0.080 |
Why?
|
| Biocatalysis | 1 | 2009 | 22 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2009 | 54 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 129 | 0.080 |
Why?
|
| Histidine | 1 | 2009 | 50 | 0.080 |
Why?
|
| Cysteine | 1 | 2009 | 67 | 0.080 |
Why?
|
| Ligands | 1 | 2009 | 168 | 0.080 |
Why?
|
| Crystallography, X-Ray | 3 | 2004 | 214 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 26 | 0.070 |
Why?
|
| Kinetics | 2 | 2012 | 538 | 0.070 |
Why?
|
| Amino Acid Motifs | 3 | 2012 | 66 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 205 | 0.070 |
Why?
|
| Nucleotides | 1 | 2006 | 19 | 0.070 |
Why?
|
| Lymphocytes | 1 | 2006 | 83 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2004 | 5 | 0.060 |
Why?
|
| Plasminogen | 1 | 2004 | 8 | 0.060 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2004 | 29 | 0.060 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 31 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2004 | 58 | 0.060 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 32 | 0.060 |
Why?
|
| Metals | 1 | 2004 | 39 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cytosol | 1 | 2003 | 47 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 408 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 25 | 0.050 |
Why?
|
| DNA, Single-Stranded | 1 | 2003 | 8 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 30 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 50 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 121 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 274 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2022 | 8 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 276 | 0.050 |
Why?
|
| Trypsin | 1 | 2001 | 24 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 130 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 165 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 588 | 0.050 |
Why?
|
| Calcium | 2 | 2011 | 231 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2021 | 142 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 393 | 0.040 |
Why?
|
| Titrimetry | 1 | 1999 | 6 | 0.040 |
Why?
|
| Lung | 1 | 2022 | 346 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1999 | 62 | 0.040 |
Why?
|
| Cytokines | 1 | 2021 | 437 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2012 | 67 | 0.040 |
Why?
|
| Transfection | 1 | 1999 | 312 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 624 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2010 | 200 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 1394 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1474 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 1996 | 28 | 0.030 |
Why?
|
| Opsins | 1 | 2016 | 18 | 0.030 |
Why?
|
| Cadmium | 1 | 1994 | 14 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 69 | 0.030 |
Why?
|
| Thermodynamics | 1 | 1994 | 86 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1994 | 90 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 781 | 0.030 |
Why?
|
| Maltose-Binding Proteins | 1 | 2012 | 5 | 0.030 |
Why?
|
| Tetraspanins | 1 | 2012 | 36 | 0.030 |
Why?
|
| Peripherins | 1 | 2012 | 47 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2011 | 27 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 1991 | 34 | 0.020 |
Why?
|
| Horses | 1 | 1991 | 34 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 90 | 0.020 |
Why?
|
| Diterpenes | 1 | 2011 | 19 | 0.020 |
Why?
|
| Vitamin A | 1 | 2011 | 25 | 0.020 |
Why?
|
| Chickens | 1 | 2011 | 59 | 0.020 |
Why?
|
| Pressure | 1 | 1991 | 88 | 0.020 |
Why?
|
| Amino Acids | 1 | 1991 | 80 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 383 | 0.020 |
Why?
|
| Kidney | 1 | 2011 | 274 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 110 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2010 | 150 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 110 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 466 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 1259 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 503 | 0.020 |
Why?
|
| Rats | 1 | 1991 | 1536 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 446 | 0.020 |
Why?
|
| Female | 1 | 2021 | 14462 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 6 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 2004 | 7 | 0.010 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2004 | 31 | 0.010 |
Why?
|
| Chromogenic Compounds | 1 | 2004 | 2 | 0.010 |
Why?
|
| Streptokinase | 1 | 2004 | 4 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2004 | 43 | 0.010 |
Why?
|
| Pliability | 1 | 2004 | 6 | 0.010 |
Why?
|
| Methionine | 1 | 2004 | 37 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2004 | 34 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2004 | 37 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 102 | 0.010 |
Why?
|
| Lysine | 1 | 2004 | 71 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 152 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 262 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2003 | 10 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2003 | 20 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2003 | 23 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 76 | 0.010 |
Why?
|
| Polymers | 1 | 2004 | 114 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 1997 | 39 | 0.010 |
Why?
|
| Crystallization | 1 | 1997 | 47 | 0.010 |
Why?
|